Insufficient evaluation of adverse events is not a proof of safety

Diabetologia. 2010 Apr;53(4):790-2; author reply 793-4. doi: 10.1007/s00125-009-1654-7. Epub 2010 Jan 23.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin Glargine
  • Insulin, Long-Acting
  • Meta-Analysis as Topic
  • Neoplasms / chemically induced*
  • Randomized Controlled Trials as Topic
  • Safety

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine